Vaccination considerations for persons with underlying medication conditions | Centers for Disease Control and Prevention |
---|---|
Centers for Disease Control and Prevention | Centers for Disease Control and Prevention |
Use of Pfizer-BioNTech COVID-19 vaccine: Clinical considerations.
28Pfizer-BioNTech vaccine: Fact sheet for recipients and caregivers | Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera |
---|---|
Information about COVID-19 vaccines for people with allergies | FDA for emergency use authorization |
Centers for Disease Control and Prevention.
29